申请人:Merck Sharp & Dohme Limited
公开号:US05728695A1
公开(公告)日:1998-03-17
The present invention relates to spiroketal derivatives of formula (I) and pharmaceutically acceptable salts thereof wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.9a, R.sup.9b, m and n are as defined in the specification, and to processes for their preparation, to intermediates used in their synthesis, to pharmaceutical compositions containing them, and to their use in therapy. The compounds are of particular use in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia. ##STR1##
本发明涉及公式(I)的螺内酯衍生物及其药学上可接受的盐,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.9a、R.sup.9b、m和n如规范中所定义,并涉及用于它们合成的中间体、含有它们的制药组合物以及它们在治疗中的应用。这些化合物特别适用于治疗或预防疼痛、炎症、偏头痛、呕吐和带状疱疹后神经痛。##STR1##